---
title: Telum Therapeutics raises €18 million to advance treatments for hospital-acquired infections
description: A post on Telum Therapeutics’ announcement that it raised €18 million in a Series A financing round led by AMR Action Fund.
---

[AMR Action Fund 2022 ](https://www.amractionfund.com/blog)

# [Telum Therapeutics raises €18 million to advance treatments for hospital-acquired infections](https://www.amractionfund.com/blog/telum-therapeutics-raises-18-million-to-advance-treatments-for-hospital-acquired-infections)

 Written by [admin](https://www.amractionfund.com/blog/author/admin) | Jul 1, 2026 7:00:11 PM

Numerous outlets reported on Telum Therapeutics’ announcement that it raised €18 million in a Series A financing round led by AMR Action Fund.

EU-Startups reported that Telum’s announcement “sits alongside several sizeable and relevant European BioTech and drug discovery financings this year.” The article also included a quote from AMR Action Fund CEO Henry Skinner, who said:

*"Acinetobacter baumannii *is one of the most formidable bacterial threats in modern medicine. It is clinically challenging, often resistant to first-line therapies, and a pathogen for which progress has been slow and difficult to achieve. We are encouraged by Telum’s novel approach and pleased to support the team as they work to bring forward a new treatment option for patients with life-threatening infections.”

Read the [full article here](https://www.eu-startups.com/2026/07/telum-therapeutics-raised-e18-million-to-advance-treatments-for-hospital-acquired-infections/).

[View full post](https://www.amractionfund.com/blog/telum-therapeutics-raises-18-million-to-advance-treatments-for-hospital-acquired-infections)

```json
{
  "@context" : "http://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "admin"
  },
  "dateModified" : "2026-07-01T19:00:11.893Z",
  "datePublished" : "2026-07-01T19:00:11Z",
  "headline" : "Telum Therapeutics raises €18 million to advance treatments for hospital-acquired infections",
  "image" : {
    "@type" : "ImageObject",
    "height" : 60,
    "url" : "/hs/hsstatic/content_shared_assets/static-1.4092/img/default-amp-logo.png",
    "width" : 60
  },
  "mainEntityOfPage" : "https://www.amractionfund.com/blog/telum-therapeutics-raises-18-million-to-advance-treatments-for-hospital-acquired-infections",
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "height" : 60,
      "url" : "/hs/hsstatic/content_shared_assets/static-1.4092/img/default-amp-logo.png",
      "width" : 60
    },
    "name" : "AMR Action Fund 2022"
  }
}
```